Stacey L. Webb, MPA-HCA, BSN, RN, ONN-CG
Baylor Charles A. Sammons Cancer CenterDallas, TXAuthored Items
Nora J. Barrett, BSN, RN, OCN, ONN-CG, Kristi C. Garrison, MS, CHES, CHW, OPN-CG, Stacey L. Webb, MPA-HCA, BSN, RN, ONN-CG
November 14, 2017 | November 2017 Vol 8, No 11
Currently, pancreatic cancer (PC) is the fourth leading cause of cancer mortality in the United States. However, with the lack of early detection tests and treatment options, it is estimated that PC may move to the second leading cause of cancer death in the United States by 2020 or even earlier.
Nora J. Barrett, BSN, RN, OCN, ONN-CG, Kristi L. Case, MS, CHES, CHW, Stacey L. Webb, MPA-HCA, BSN, RN, ONN-CG
September 23, 2016 | October 2016 Vol 7, No 9
Due to the lack of effective medical treatments for the most common type, pancreatic ductal adenocarcinoma (PDAC), early detection is imperative in treating the disease.
Nora J. Barrett, BSN, RN, OCN, ONN-CG, Kristi L. Case, MS, CHES, CHW, Stacey L. Webb, MPA-HCA, BSN, RN, ONN-CG
June 7, 2016 | June 2016 Vol 7, No 5
The authors present their report on decreasing the time between the physician’s order for LDCT and date of actual screening.
Last modified: December 18, 2018